Lord, Abbett & Co’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-245,653
Closed -$4.48M 821
2017
Q4
$4.48M Sell
245,653
-59,260
-19% -$1.17M 0.01% 768
2017
Q3
$6.82M Buy
+304,913
New +$6.89M 0.02% 704
2016
Q2
Sell
-86,920
Closed -$1.46M 870
2016
Q1
$1.46M Sell
86,920
-121,260
-58% -$2.13M ﹤0.01% 849
2015
Q4
$4.67M Sell
208,180
-219,379
-51% -$4.52M 0.01% 754
2015
Q3
$9.37M Sell
427,559
-25,303
-6% -$632K 0.03% 605
2015
Q2
$11.2M Buy
452,862
+203,499
+82% +$4.54M 0.03% 619
2015
Q1
$5.11M Buy
249,363
+7,457
+3% +$144K 0.01% 738
2014
Q4
$4.83M Buy
241,906
+90,107
+59% +$1.55M 0.01% 737
2014
Q3
$2.23M Sell
151,799
-95,135
-39% -$1.52M 0.01% 877
2014
Q2
$4.54M Sell
246,934
-69,135
-22% -$1.15M 0.01% 820
2014
Q1
$5.95M Buy
+316,069
New +$6.48M 0.01% 765

Other funds holding ATRC

Lord, Abbett & Co's ATRC Position: Q1 2018 in Review

Lord, Abbett & Co sold out of AtriCure (ATRC) in Q1 2018, closing a stake of 245,653 shares — an estimated $4.48M sold.

Lord, Abbett & Co first reported a position in ATRC in Q1 2014 and held it in 11 quarters. The position peaked at $11.2M in Q2 2015. 108 funds tracked by Wall St. Rank hold ATRC as of Q1 2018.

  • Lord, Abbett & Co reported no remaining AtriCure position as of Q1 2018 after selling out during the quarter.
  • Lord, Abbett & Co sold 245,653 AtriCure shares in Q1 2018, an estimated $4.48M.
  • Lord, Abbett & Co first reported a position in AtriCure in Q1 2014 and held it in 11 quarters.
  • Lord, Abbett & Co's AtriCure position peaked at $11.2M in Q2 2015.
  • 108 funds tracked by Wall St. Rank held AtriCure as of Q1 2018.

Based on Lord, Abbett & Co's 13F filing for Q1 2018, filed 15 May 2018.